Literature DB >> 31602835

[Experts consensus statement on Xiyanping Injection in clinical practice(children)].

Zhi-Fei Wang1, Ping Rong2, Rong Ma2, Yan-Ming Xie1, Ying Ding3, Xue-Feng Wang4, Si-Yan Zhan5, Xiu-Hui Li6.   

Abstract

Xiyanping Injection is a commonly used medicine in clinical treatment,which is recommended by many pediatric disease guidelines/consensus. However,the instraction is relatively simple and lack of guidance for clinical application,which affects the efficacy and brings safety risks. Therefore,more detailed clinical guidance is urgently needed. This consensus is formulated by clinical experts of traditional Chinese medicine and Western medicine in pediatrics. This consensus follows Manual for the clinical experts consensus of Chinese patent medicine which published by China Association of Chinese Medicine. The study identified clinical problems using clinical investigation,searched the literature based on PICO clinical problems,using GRADE system to carry out evidences evaluation,classification and recommendation,and adopted the nominal grouping method to reach expert consensus. The consensus combines evidence-based evidence with expert experience,sufficient evidence of clinical problems would lead to " recommendations",and clinical problems with insufficient evidence will lead to " consensus suggestions". This expert consensus recommends the indications,intervention time for treatment,route of drug administration,dose conversion,the indications of being used alone,suitability and taboos of medicine combination,and introduces the safety and clinical application,to provide reference for clinical using.

Entities:  

Keywords:  Xiyanping Injection; classification of evidence; clinical application; expert consensus; recommendation

Mesh:

Substances:

Year:  2019        PMID: 31602835     DOI: 10.19540/j.cnki.cjcmm.20190521.502

Source DB:  PubMed          Journal:  Zhongguo Zhong Yao Za Zhi        ISSN: 1001-5302


  2 in total

1.  The Pharmacological Mechanism of Xiyanping Injection for the Treatment of Novel Coronavirus Pneumonia (COVID-19): Based on Network Pharmacology Strategy.

Authors:  Liang-Jing Xia; Liang-Ming Zhang; Kun Yang; Tong Chen; Xian-Wen Ye; Zi-Jun Yan
Journal:  Evid Based Complement Alternat Med       Date:  2022-07-08       Impact factor: 2.650

2.  Traditional Chinese Medicine Injections Combined With Oseltamivir for Influenza: Systematic Review and Network Meta-Analysis.

Authors:  Yingying Peng; Zhe Chen; Huanmin Li; Yaowei Han; Dan Sun; Yanjiao Li; Xiaoxia Wu; Hongxiang Chen; Xinmin Li
Journal:  Front Pharmacol       Date:  2022-07-22       Impact factor: 5.988

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.